Kintsugi stands out as a leader in the mental healthcare industry, leveraging their unique voice biomarker software to detect signs of depression and anxiety, a technology that has earned them recognition from Forbes as one of the Top 50 AI companies to watch in 2022. Their strategic partnership with the Pega platform enables healthcare providers and payers to address mental health concerns in real-time during calls, potentially impacting millions of Americans. Kintsugi's commitment to bridging the gap in mental healthcare access, coupled with their advanced technology, positions them as a company that is not only addressing a critical societal issue but also shaping the future of mental healthcare.